Does comorbidity interact with prostate cancer to increase mortality? A Danish cohort study of 45 326 prostate cancer patients diagnosed during 1995–2011

References

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917.
   PubMed Web of Science ®Google Scholar
• Cancerregisteret. Tal og analyse. 2012. [cited 2014 Sep 10]. Available from: http://www.ssi.dk/~/media/Indhold/DK%20-%20dansk/Sundhedsdata%20og%20it/NSF/Registre/Cancerregisteret/Cancerregisteret%202012.ashx.
   Google Scholar
• Borre M, Erichsen R, Lund L, Larsen EH, Norgaard M, Jacobsen JB. Survival of prostate cancer patients in Central and Northern Denmark, 1998–2009. Clin Epidemiol 2011;3(Suppl 1):41–6.
   PubMedGoogle Scholar
• Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012;61:1079–92.
   PubMed Web of Science ®Google Scholar
• Nguyen-Nielsen M, Norgaard M, Jacobsen JB, Borre M, Thomsen RW, Sogaard M. Comorbidity and survival of Danish prostate cancer patients from 2000–2011: A population-based cohort study. Clin Epidemiol 2013;5(Suppl 1):47–55.
   PubMedGoogle Scholar
• Daskivich TJ, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, et al. Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med 2013;158:709–17.
   PubMed Web of Science ®Google Scholar
• Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006;53:441–9.
   PubMed Web of Science ®Google Scholar
• Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011;39(7 Suppl):42–5.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 2014;29:541–9.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373–83.
   PubMedGoogle Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;39(7 Suppl):30–3.
   PubMed Web of Science ®Google Scholar
• Jespersen CG, Borre M, Norgaard M. Validity of the recorded codes of gonadotropin-releasing hormone agonist treatment and orchiectomies in the Danish National Patient Registry. Clin Epidemiol 2012;4:145–9.
   PubMedGoogle Scholar
• Launay-Vacher V, Oudard S, Janus N, Gligorov J, Pourrat X, Rixe O, et al. Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: The renal insufficiency and anticancer medications (IRMA) study. Cancer 2007;110:1376–84.
   PubMed Web of Science ®Google Scholar
• Raji MA, Kuo YF, Freeman JL, Goodwin JS. Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer: Implications for cancer care. Arch Intern Med 2008;168:2033–40.
   PubMed Web of Science ®Google Scholar
• Roder MA, Brasso K, Christensen IJ, Johansen J, Langkilde NC, Hvarness H, et al. Changes in preoperative characteristics in patients undergoing radical prostatectomy – a 16-year nationwide analysis. Acta Oncol 2014;53:361–7.
   PubMed Web of Science ®Google Scholar
• Klotz L. Active surveillance for prostate cancer: Overview and update. Curr Treat Options Oncol 2013;14:97–108.
   PubMed Web of Science ®Google Scholar
• Hjertholm P, Fenger-Gron M, Vestergaard M, Christensen MB, Borre M, Moller H, et al. Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: An ecological study. Int J Cancer 2015;136:435–42.
   PubMed Web of Science ®Google Scholar
• Roder MA, Brasso K, Berg KD, Thomsen FB, Gruschy L, Rusch E, et al. Patients undergoing radical prostatectomy have a better survival than the background population. Dan Med J 2013;60:A4612.
   Google Scholar
• Gutt R, Tonlaar N, Kunnavakkam R, Karrison T, Weichselbaum RR, Liauw SL. Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. J Clin Oncol 2010;28:2653–9.
   PubMed Web of Science ®Google Scholar
• Spratt DE, Zhang C, Zumsteg ZS, Pei X, Zhang Z, Zelefsky MJ. Metformin and prostate cancer: Reduced development of castration-resistant disease and prostate cancer mortality. Eur Urol 2013;63: 709–16.
   PubMed Web of Science ®Google Scholar
• Erichsen R, Horvath-Puho E, Iversen LH, Lash TL, Sorensen HT. Does comorbidity interact with colorectal cancer to increase mortality? A nationwide population-based cohort study. Br J Cancer 2013;109: 2005–13.
   PubMed Web of Science ®Google Scholar
• Ording AG, Garne JP, Nystrom PM, Froslev T, Sorensen HT, Lash TL. Comorbid diseases interact with breast cancer to affect mortality in the first year after diagnosis – a Danish Nationwide Matched Cohort Study. PLoS One 2013;8:e76013.
   PubMed Web of Science ®Google Scholar
• Lemmens VE, Janssen-Heijnen ML, Verheij CD, Houterman S, Repelaer van Driel OJ, Coebergh JW. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg 2005;92:615–23.
   PubMed Web of Science ®Google Scholar
• Cho H, Mariotto AB, Mann BS, Klabunde CN, Feuer EJ. Assessing non-cancer-related health status of US cancer patients: Other-cause survival and comorbidity prevalence. Am J Epidemiol 2013;178:339–49.
   PubMed Web of Science ®Google Scholar
• Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011;11:83.
   PubMed Web of Science ®Google Scholar